S100A8/A9: A Janus-faced molecule in cancer therapy and tumorgenesis

European Journal of Pharmacology

Volumn 625, Issue 1-3, 2009, Pages 73-83

  Ghavami, Saeid ^a   Chitayat, Seth ^b   Hashemi, Mohammad ^c   Eshraghi, Mehdi ^a   Chazin, Walter J ^b   Halayko, Andrew J ^a   Kerkhoff, Claus ^d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Apoptotic agent; Chemoattractance; Growth arrest; Immune escape; Metastasis; Reactive oxygen species; Stress response; Tumorgenesis

Indexed keywords

CALGRANULIN A; CALGRANULIN B; JANUS KINASE; PROTEIN S 100;

APOPTOSIS; BONE MARROW CELL; CANCER CELL; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE ARREST; CELL MIGRATION; CELL PROLIFERATION; CELL STRESS; EPITHELIUM CELL; GENE EXPRESSION; GENE STRUCTURE; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; APOPTOSIS; CALGRANULIN A; CALGRANULIN B; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOTHERAPY; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 71749091786     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.08.044     Document Type: Review

References (150)

1. Arai K., Teratani T., Nozawa R., and Yamada T. Immunohistochemical investigation of S100A9 expression in pulmonary adenocarcinoma: S100A9 expression is associated with tumor differentiation. Oncol. Rep. 8 (2001) 591-596
2. Arai K., Teratani T., Kuruto-Niwa R., Yamada T., and Nozawa R. S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation. Eur. J. Cancer 40 (2004) 1179-1187
3. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
4. Bartling B., Rehbein G., Schmitt W.D., Hofmann H.S., Silber R.E., and Simm A. S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: impairment by advanced tumor stages and neoadjuvant chemotherapy. Eur. J. Cancer 43 (2007) 1935-1943
5. Beer D.G., Kardia S.L., Huang C.C., Giordano T.J., Levin A.M., Misek D.E., Lin L., Chen G., Gharib T.G., Thomas D.G., Lizyness M.L., Kuick R., Hayasaka S., Taylor J.M., Iannettoni M.D., Orringer M.B., and Hanash S. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med. 8 (2002) 816-824
6. Benedyk M., Sopalla C., Nacken W., Bode G., Melkonyan H., Banfi B., and Kerkhoff C. HaCaT keratinocytes overexpressing the S100 proteins S100A8 and S100A9 show increased NADPH oxidase and NF-kappaB activities. J. Invest. Dermatol. 127 (2007) 2001-2011
7. Bhardwaj R.S., Zotz C., Zwadlo-Klarwasser G., Roth J., Goebeler M., Mahnke K., Falk M., Meinardus-Hager G., and Sorg C. The calcium-binding proteins MRP8 and MRP14 form a membrane-associated heterodimer in a subset of monocytes/macrophages present in acute but absent in chronic inflammatory lesions. Eur. J. Immunol. 22 (1992) 1891-1897
8. 2+/S100B/NDR kinase peptide complex: insights into S100 target specificity and activation of the kinase. Biochemistry 42 (2003) 14416-14426
9. Bode G., Lüken A., Kerkhoff C., Roth J., Ludwig S., and Nacken W. Interaction between S100A8/A9 and annexin A6 is involved in the calcium-induced cell surface exposition of S100A8/A9. J. Biol. Chem. 283 (2008) 31776-31784
10. Brandtzaeg P., Dale I., and Fagerhol M.K. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia. Am. J. Clin. Pathol. 87 (1987) 700-707
11. Broome A., Ryan D., and Eckert R.L. S100 protein subcellular localization during epidermal differentiation and psoriasis. J. Histochem. Cytochem. 51 (2003) 675-685
12. Carlsson H., Petersson S., and Enerbäck C. Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development. Int. J. Oncol. 27 (2005) 1473-1481
13. Cheng P., Corzo C.A., Luetteke N., Yu B., Nagaraj S., Bui M.M., Ortiz M., Nacken W., Sorg C., Vogl T., Roth J., and Gabrilovich D.I. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med. 205 (2008) 2235-2249
14. Clohessy P.A., and Golden B.E. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defence. Scand. J. Immunol. 42 (1995) 551-556
15. Corbin B.D., Seeley E.H., Raab A., Feldmann J., Miller M.R., Torres V.J., Anderson K.L., Dattilo B.M., Dunman P.M., Gerads R., Caprioli R.M., Nacken W., Chazin W.J., and Skaar E.P. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319 (2008) 962-965
16. Cross S.S., Hamdy F.C., Deloulme J.C., and Rehman I. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 46 (2005) 256-269
17. Dazard J., Gal H., Amariglio N., Rechavi G., Domany E., and Givol D. Genome-wide comparison of human keratinocyte and squamous cell carcinoma responses to UVB irradiation: implications for skin and epithelial cancer. Oncogene 22 (2003) 2993-3006
18. Dianoux A.C., Stasia M.J., Garin J., Gagnon J., and Vignais P.V. The 23-kilodalton protein, a substrate of protein kinase C, in bovine neutrophil cytosol is a member of the S100 family. Biochemistry 31 (1992) 5898-5905
19. Diederichs S., Bulk E., Steffen B., Ji P., Tickenbrock L., Lang K., Zänker K.S., Metzger R., Schneider P.M., Gerke V., Thomas M., Berdel W.E., Serve H., and Müller-Tidow C. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res. 64 (2004) 5564-5569
20. Donato R. S-100 proteins. Cell Calcium 7 (1986) 123-145
21. Donato R. Perspectives in S-100 protein biology. Cell Calcium 12 (1991) 713-726
22. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33 (2001) 637-668
23. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc. Res. Tech. 60 (2003) 540-551
24. Donato R. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr. Mol. Med. 7 (2007) 711-724
25. Doussiere J., Bouzidi F., Poinas A., Gaillard J., and Vignais P.V. Kinetic study of the activation of the neutrophil NADPH oxidase by arachidonic acid. Antagonistic effects of arachidonic acid and phenylarsine oxide. Biochemistry 38 (1999) 16394-16406
26. 2+-binding protein family. Genes Dev. 3 (1989) 1086-1093
27. Eckert R.L., Broome A., Ruse M., Robinson N., Ryan D., and Lee K. S100 proteins in the epidermis. J. Invest. Dermatol. 123 (2004) 23-33
28. Emberley E.D., Murphy L.C., and Watson P.H. S100A7 and the progression of breast cancer. Breast Cancer Res. 6 (2004) 153-159
29. Feng G., Xu X., Youssef E.M., and Lotan R. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis. Cancer Res. 61 (2001) 7999-8004
30. Fernandez-Fernandez M.R., Rutherford T.J., and Fersht A.R. Members of the S100 family bind p53 in two distinct ways. Protein Sci. 17 (2008) 1663-1670
31. Garrett S.G., Varney K.M., Weber D.J., and Bresnick A.R. S100A4, a mediator of metastasis. J. Biol. Chem. 281 (2006) 677-680
32. Gebhardt C., Riehl A., Durchdewald M., Nemeth J., Furstenberger G., Muller-Decker K., Enk A., Arnold B., Bierhaus A., Nawroth P.P., Hess J., and Angel P. RAGE signaling sustains inflammation and promotes tumor development. J. Exp. Med. 205 (2008) 275-285
33. Ghavami S., Kerkhoff C., Los M., Hashemi M., Sorg C., and Karami-Tehrani F. Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J. Leukoc. Biol. 76 (2004) 169-175
34. Ghavami S., Kerkhoff C., Chazin W.J., Kadkhoda K., Xiao W., Zuse A., Hashemi M., Eshraghi M., Schulze-Osthoff K., Klonisch T., and Los M. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim. Biophys. Acta 1783 (2008) 297-311
35. Ghavami S., Rashedi I., Dattilo B.M., Eshraghi M., Chazin W.J., Hashemi M., Wesselborg S., Kerkhoff C., and Los M. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J. Leukoc. Biol. 83 (2008) 1484-1492
36. Gimbrone Jr. M.A., Bevilacqua M.P., and Cybulsky M.I. Endothelial-dependent mechanisms of leukocyte adhesion in inflammation and atherosclerosis. Ann. N. Y. Acad. Sci. 598 (1990) 77-85
37. Gribenko A.V., Hopper J.E., and Makhatadze G.I. Molecular characterization and tissue distribution of a novel member of the S100 family of EF-hand proteins. Biochemistry 40 (2001) 15538-15548
38. Grigorian M., Andresen S., Tulchinsky E., Kriajevska M., Carlberg C., Kruse C., Cohn M., Ambartsumian N., Christensen A., Selivanova G., and Lukanidin E. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J. Biol. Chem. 276 (2001) 22699-22708
39. Grote J., König S., Ackermann D., Sopalla C., Benedyk M., Los M., and Kerkhoff C. Identification of poly(ADP-ribose)polymerase-1 and Ku70/Ku80 as transcriptional regulators of S100A9 gene expression. BMC Mol. Biol. 7 (2006) 48
40. Groves P., Finn B.E., Kuznicki J., and Forsen S. A model for target protein binding to calcium-activated S100 dimers. FEBS Lett. 421 (1998) 175-179
41. Guignard F., Mauel J., and Markert M. Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochem. J. 309 (1995) 395-401
42. Hardas B.D., Zhao X., Zhang J., Longqing X., Stoll S., and Elder J.T. Assignment of psoriasin to human chromosomal band 1q21: coordinate overexpression of clustered genes in psoriasis. J. Invest. Dermatol. 106 (1996) 753-758
43. Hashemi M., Ghavami S., Eshraghi M., Booy E.P., and Los M. Cytotoxic effects of intra and extracellular zinc chelation on human breast cancer cells. Eur. J. Pharmacol. 557 (2007) 9-19
44. Heizmann C.W. The multifunctional S100 protein family. Methods Mol. Biol. 172 (2002) 69-80
45. Heizmann C.W., Fritz G., and Schafer B.W. S100 proteins: structure, functions and pathology. Front Biosci. 7 (2002) d1356-d1368
46. Heizmann C.W., Ackermann G.E., and Galichet A. Pathologies involving the S100 proteins and RAGE. Subcell. Biochem. 45 (2007) 93-138
47. Helfman D.M., Kim E.J., Lukanidin E., and Grigorian M. The metastasis associated protein S100A4: role in tumor progression and metastasis. Br. J. Cancer 92 (2005) 1955-1958
48. Hermani A., Hess J., De Servi B., Medunjanin S., Grobholz R., Trojan L., Angel P., and Mayer D. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin. Cancer Res. 11 (2005) 5146-5152
49. Herold K., Moser B., Chen Y., Zeng S., Yan S.F., Ramasamy R., Emond J., Clynes R., and Schmidt A.M. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress. J. Leukoc. Biol. 82 (2007) 204-212
50. Hiratsuka S., Watanabe A., Aburatani H., and Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8 (2006) 1369-1375
51. Hiratsuka S., Watanabe A., Sakurai Y., Akashi-Takamura S., Ishibashi S., Miyake K., Shibuya M., Akira S., Aburatani H., and Maru Y. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat. Cell Biol. 10 (2008) 1349-1355
52. Hobbs J.A., May R., Tanousis K., McNeill E., Mathies M., Gebhardt C., Henderson R., Robinson M.J., and Hogg N. Myeloid cell function in MRP-14 (S100A9) null mice. Mol. Cell. Biol. 23 (2003) 2564-2576
53. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M.F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., and Schmidt A.M. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97 (1999) 889-901
54. Hogg N., Allen C., and Edgeworth J. Monoclonal antibody 5.5 reacts with p8, 14, a myeloid molecule associated with some vascular endothelium. Eur. J. Immunol. 19 (1989) 1053-1061
55. Hummerich L., Muller R., Hess J., Kokocinski F., Hahn M., Furstenberger G., Mauch C., Lichter P., and Angel P. Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development. Oncogene 25 (2006) 111-121
56. Hunter M.J., and Chazin W.J. High level expression and dimer characterization of the S100 EF-hand proteins, migration inhibitory factor-related proteins 8 and 14. J. Biol. Chem. 273 (1998) 12427-12435
57. Igney F.H., and Krammer P.H. Immune escape of tumors: apoptosis resistance and tumor counterattack. J. Leukoc. Biol. 71 (2002) 907-920
58. Ilg E.C., Schafer B.W., and Heizmann C.W. Expression pattern of S100 calcium-binding proteins in human tumors. Int. J. Cancer 68 (1996) 325-332
59. Ito Y., Arai K., Ryushi Nozawa Yoshida H., Tomoda C., Uruno T., Miya A., Kobayashi K., Matsuzuka F., Kuma K., Kakudo K., and Miyauchi A. S100A9 expression is significantly linked to dedifferentiation of thyroid carcinoma. Pathol. Res. Pract. 201 (2005) 551-556
60. Ji J., Zhao L., Wang X., Zhou C., Ding F., Su L., Zhang C., Mao X., Wu M., and Liu Z. Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 130 (2004) 480-486
61. Kane D., Roth J., Frosch M., Vogl T., Bresnihan B., and FitzGerald O. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. Arthritis Rheum. 48 (2003) 1676-1685
62. Karin M., and Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5 (2005) 749-759
63. Kerkhoff C., and Ghavami S. Induction of apoptotic cell death in tumor cells by S100A8/A9 released from inflammatory cells upon cellular activation. Curr. Med. Chem. Anti-Inflamm. Anti-Allergy Agents 4 (2005) 383-391
64. Kerkhoff C., Klempt M., and Sorg C. Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim. Biophys. Acta 1448 (1998) 200-211
65. Kerkhoff C., Klempt M., Kaever V., and Sorg C. The two calcium-binding proteins, S100A8 and S100A9, are involved in the metabolism of arachidonic acid in human neutrophils. J. Biol. Chem. 274 (1999) 32672-32679
66. Kerkhoff C., Sorg C., Tandon N.N., and Nacken W. Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells. Biochemistry 40 (2001) 241-248
67. Kerkhoff C., Hofmann H.A., Vormoor J., Melkonyan H., Roth J., Sorg C., and Klempt M. Binding of two nuclear complexes to a novel regulatory element within the human S100A9 promoter drives the S100A9 gene expression. J. Biol. Chem. 277 (2002) 41879-41887
68. Kerkhoff C., Nacken W., Benedyk M., Dagher M.C., Sopalla C., and Doussiere J. The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2. FASEB J. 19 (2005) 467-469
69. Kim Y.J., Kim M.A., Im S.A., Kim T.M., Kim D.W., Yang H.K., Heo D.S., Lee K.U., Choe K.J., Kim N.K., Kim T.Y., Kim W.H., and Bang Y.J. Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer. Cancer Invest. 26 (2008) 152-158
70. Korndörfer I.P., Brueckner F., and Skerra A. The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins. J. Mol. Biol. 370 (2007) 887-898
71. Lackmann M., Cornish C.J., Simpson R.J., Moritz R.L., and Geczy C.L. Purification and structural analysis of a murine chemotactic cytokine (CP-10) with sequence homology to S100 proteins. J. Biol. Chem. 267 (1992) 7499-7504
72. Lagasse E., and Clerc R.G. Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation. Mol. Cell. Biol. 8 (1988) 2402-2410
73. Li C., Zhang F., Lin M., and Liu J. Induction of S100A9 gene expression by cytokine oncostatin M in breast cancer cells through the STAT3 signaling cascade. Breast Cancer Res. Treat. 87 (2004) 123-134
74. Liu D., Rudland P.S., Sibson D.R., Platt-Higgins A., and Barraclough R. Expression of calcium-binding protein S100A2 in breast lesions. Br. J. Cancer 83 (2000) 1473-1479
75. Liu J., Li X., Dong G.L., Zhang H.W., Chen D.L., Du J.J., Zheng J.Y., Li J.P., and Wang W.Z. In silico analysis and verification of S100 gene expression in gastric cancer. BMC Cancer 8 (2008) 261
76. Loomans H.J., Hahn B.L., Li Q.Q., Phadnis S.H., and Sohnle P.G. Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin. J. Infect. Dis. 177 (1998) 812-814
77. Luo J.L., Maeda S., Hsu L.C., Yagita H., and Karin M. Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 6 (2004) 297-305
78. Luthra M.G., Ajani J.A., Izzo J., Ensor J., Wu T.T., Rashid A., Zhang L., Phan A., Fukami N., and Luthra R. Decreased expression of gene cluster at chromosome 1q21 defines molecular subgroups of chemoradiotherapy response in esophageal cancers. Clin. Cancer Res. 13 (2007) 912-919
79. Madsen P., Rasmussen H.H., Leffers H., Honoré B., and Celis J.E. Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. J. Invest. Dermatol. 99 (1992) 299-305
80. Maelandsmo G.M., Florenes V.A., Mellingsaeter T., Hovig E., Kerbel R.S., and Fodstad O. Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. Int. J. Cancer 74 (1997) 464-469
81. Manitz M.P., Horst B., Seeliger S., Strey A., Skryabin B.V., Gunzer M., Frings W., Schönlau F., Roth J., Sorg C., and Nacken W. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol. Cell. Biol. 23 (2003) 1034-1043
82. Marionnet C., Bernerd F., Dumas A., Verrecchia F., Mollier K., Compan D., Bernard B., Lahfa M., Leclaire J., Medaisko C., Mehul B., Seite S., Mauviel A., and Dubertret L. Modulation of gene expression induced in human epidermis by environmental stress in vivo. J. Invest. Dermatol. 121 (2003) 1447-1458
83. Mischke D., Korge B.P., Marenholz I., Volz A., and Ziegler A. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ("epidermal differentiation complex") on human chromosome 1q21. J. Invest. Dermatol. 106 (1996) 989-992
84. Miyasaki K.T., Bodeau A.L., Murthy A.R., and Lehrer R.I.J. In vitro antimicrobial activity of the human neutrophil cytosolic S-100 protein complex, calprotectin, against Capnocytophaga sputigena. Dent. Res. 72 (1993) 517-523
85. Molina R., Navarro J., Filella X., Castel T., and Ballesta A.M. S-100 protein serum levels in patients with benign and malignant diseases: false-positive results related to liver and renal function. Tumour Biol. 23 (2002) 39-44
86. Moroz O.V., Dodson G.G., Wilson K.S., Lukanidin E., and Bronstein I.B. Multiple structural states of S100A12: a key to its functional diversity. Microsc. Res. Tech. 60 (2003) 581-592
87. Mueller A., Schafer B.W., Ferrari S., Weibel M., Makek M., Hochli M., and Heizmann C.W. The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J. Biol. Chem. 280 (2005) 29186-29193
88. Murao S., Collart F., and Huberman E. A protein complex expressed during terminal differentiation of monomyelocytic cells is an inhibitor of cell growth. Cell Growth Differ. 1 (1990) 447-454
89. Murthy A.R., Lehrer R.I., Harwig S.S., and Miyasaki K.T. In vitro candidastatic properties of the human neutrophil calprotectin complex. J. Immunol. 151 (1993) 6291-6301
90. Nacken W., Roth J., Sorg C., and Kerkhoff C. S100A9/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc. Res. Tech. 60 (2003) 569-580
91. Nacken W., Sorg C., and Kerkhoff C. The myeloid expressed EF-hand proteins display a diverse pattern of lipid raft association. FEBS Lett. 572 (2004) 289-293
92. Nagaraja G.M., Othman M., Fox B.P., Alsaber R., Pellegrino C.M., Zeng Y., Khanna R., Tamburini P., Swaroop A., and Kandpal R.P. Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics. Oncogene 25 (2006) 2328-2338
93. Nagpal S., Thacher S.M., Patel S., Friant S., Malhotra M., Shafer J., Krasinski G., Asano A.T., Teng M., Duvic M., and Chandraratna R.A. Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis. Cell Growth Differ. 7 (1996) 1783-1791
94. Nakatani Y., Yamazaki M., Chazin W.J., and Yui S. Regulation of S100A8/A9 (calprotectin) binding to tumor cells by zinc ion and its implication for apoptosis-inducing activity. Mediators Inflamm. 2005 (2005) 280-292
95. Odink K., Cerletti N., Bruggen J., Clerc R.G., Tarcsay L., Zwadlo G., Gerhards G., Schlegel R., and Sorg C. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330 (1987) 80-82
96. Osterloh D., Ivanenkov V.V., and Gerke V. Hydrophobic residues in the C-terminal region of S100A1 are essential for target protein binding but not for dimerization. Cell Calcium 24 (1998) 137-151
97. Pietas A., Schluns K., Marenholz I., Schafer B.W., Heizmann C.W., and Petersen I. Molecular cloning and characterization of the human S100A14 gene encoding a novel member of the S100 family. Genomics 79 (2002) 513-522
98. Pröpper C., Huang X., Roth J., Sorg C., and Nacken W. Analysis of the MRP8-MRP14 protein-protein interaction by the two-hybrid system suggests a prominent role of the C-terminal domain of S100 proteins in dimer formation. J. Biol. Chem. 274 (1999) 183-188
99. Rafii S., and Lyden D. S100 chemokines mediate bookmarking of premetastatic niches. Nat. Cell Biol. 8 (2006) 1321-1323
100. Rammes A., Roth J., Goebeler M., Klempt M., Hartmann M., and Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J. Biol. Chem. 272 (1997) 9496-9502
101. Rety S., Sopkova J., Renouard M., Osterloh D., Gerke V., Tabaries S., Russo-Marie F., and Lewit-Bentley A. The crystal structure of a complex of p11 with the annexin II N-terminal peptide. Nat. Struct. Biol. 6 (1999) 89-95
102. Rintala-Dempsey A.C., Santamaria-Kisiel L., Liao Y., Lajoie G., and Shaw G.S. Insights into S100 target specificity examined by a new interaction between S100A11 and annexin A2. Biochemistry 45 (2006) 14695-14705
103. Robinson M.J., Tessier P., Poulsom R., and Hogg N. The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J. Biol. Chem. 277 (2002) 3658-3665
104. Roth J., Burwinkel F., van den Bos C., Goebeler M., Vollmer E., and Sorg C. MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood 82 (1993) 1875-1883
105. Ruegg C. Leukocytes, inflammation, and angiogenesis in cancer: fatal attractions. J. Leukoc. Biol. 80 (2006) 682-684
106. Rustandi R.R., Baldisseri D.M., and Weber D.J. Structure of the negative regulatory domain of p53 bound to S100B(betabeta). Nat. Struct. Biol. 7 (2000) 570-574
107. Ryan J., and Geczy C.L. Characterization and purification of mouse macrophage procoagulant-inducing factor. J. Immunol. 137 (1986) 2864-2870
108. Ryckman C., Vandal K., Rouleau P., Talbot M., and Tessier P.A. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol. 170 (2003) 3233-3242
109. Salama I., Malone P.S., Mihaimeed F., and Jones J.L. A review of the S100 proteins in cancer. Eur. J. Surg. Oncol. 34 (2008) 357-364
110. Santamaria-Kisiel L., Rintala-Dempsey A.C., and Shaw G.S. Calcium-dependent and -independent interactions of the S100 protein family. Biochem. J. 396 (2006) 201-214
111. Schafer B.W., and Heizmann C.W. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem. Sci. 21 (1996) 134-140
112. Schaub M.C., and Heizmann C.W. Calcium, troponin, calmodulin, S100 proteins: from myocardial basics to new therapeutic strategies. Biochem. Biophys. Res. Commun. 369 (2008) 247-264
113. Seitz C.S., Lin Q., Deng H., and Khavari P.A. Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 2307-2312
114. Semprini S., Capon F., Tacconelli A., Giardina E., Orecchia A., Mingarelli R., Gobello T., Zambruno G., Botta A., Fabrizi G., and Novelli G. Evidence for differential S100 gene over-expression in psoriatic patients from genetically heterogeneous pedigrees. Hum. Genet. 111 (2002) 310-313
115. Seth A., Kitching R., Landberg G., Xu J., Zubovits J., and Burger A.M. Gene expression profiling of ductal carcinomas in situ and invasive breast tumors. Anticancer Res. 23 (2003) 2043-2051
116. Shen J., Person M.D., Zhu J., Abbruzzese J.L., and Li D. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res. 64 (2004) 9018-9026
117. Sohnle P.G., Collins-Lech C., and Wiessner J.H. Antimicrobial activity of an abundant calcium-binding protein in the cytoplasm of human neutrophils. J. Infect. Dis. 163 (1991) 187-192
118. Sohnle P.G., Hunter M.J., Hahn B., and Chazin W.J. Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14). J. Infect. Dis. 182 (2000) 1272-1275
119. Soo C., Sayah D.N., Zhang X., Beanes S.R., Nishimura I., Dang C., Freymiller E., and Ting K. The identification of novel wound-healing genes through differential display. Plast. Reconstr. Surg. 110 (2002) 787-797
120. Sopalla C., Leukert N., Sorg C., and Kerkhoff C. Evidence for the involvement of the unique C-tail of S100A9 in the binding of arachidonic acid to the heterocomplex S100A8/A9. Biol. Chem. 383 (2002) 1895-1905
121. Srikrishna G., Panneerselvam K., Westphal V., Abraham V., Varki A., and Freeze H.H. Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. J. Immunol. 166 (2001) 4678-4688
122. Sroussi H.Y., Berline J., and Palefsky J.M. Oxidation of methionine 63 and 83 regulates the effect of S100A9 on the migration of neutrophils in vitro. J. Leukoc. Biol. 81 (2007) 818-824
123. Steinbakk M., Naess-Andresen C.F., Lingaas E., Dale I., Brandtzaeg P., and Fagerhol M.K. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 336 (1990) 763-765
124. Stulik J., Osterreicher J., Koupilova K., Knizek M.A., Bures J., Jandik P., Langr F., Dedic K., and Jungblut P.R. The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: the S100A9 and S100A8 positive cells underlie and invade tumor mass. Electrophoresis 20 (1999) 1047-1054
125. Sturchler E., Cox J.A., Durussel I., Weibel M., and Heizmann C.W. S100A16, a novel calcium-binding protein of the EF-hand superfamily. J. Biol. Chem. 281 (2006) 38905-38917
126. Tarabykina S., Scott D.J., Herzyk P., Hill T.J., Tame J.R., Kriajevska M., Lafitte D., Derrick P.J., Dodson G.G., Maitland N.J., Lukanidin E.M., and Bronstein I.B. The dimerization interface of the metastasis-associated protein S100A4 (Mts1): in vivo and in vitro studies. J. Biol. Chem. 276 (2001) 24212-24222
127. Teigelkamp S., Bhardwaj R.S., Roth J., Meinardus-Hager G., Karas M., and Sorg C. Calcium-dependent complex assembly of the myeloic differentiation proteins MRP-8 and MRP-14. J. Biol. Chem. 266 (1991) 13462-13467
128. 2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes. J. Biol. Chem. 276 (2001) 35818-35825
129. Tian T., Hao J., Xu A., Hao J., Luo C., Liu C., Huang L., Xiao X., and He D. Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis. Cancer Sci. 98 (2007) 1265-1274
130. van Dieck J., Fernandez-Fernandez M.R., Veprintsev D.B., and Fersht A.R. Modulation of the oligomerization state of p53 by differential binding of proteins of the S100family to p53 monomers and tetramers. J. Biol. Chem. 284 (2009) 13804-13811
131. Vandal K., Rouleau P., Boivin A., Ryckman C., Talbot M., and Tessier P.A. Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J. Immunol. 171 (2003) 2602-2609
132. Vilhardt F., and van Deurs B. The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly. EMBO J. 23 (2004) 739-748
133. Vogl T., Roth J., Sorg C., Hillenkamp F., and Strupat K.J. Calcium-induced noncovalently linked tetramers of MRP8 and MRP14 detected by ultraviolet matrix-assisted laser desorption/ionization mass spectrometry. Am. Soc. Mass Spectrom. 10 (1999) 1124-1130
134. Vogl T., Ludwig S., Goebeler M., Strey A., Thorey I.S., Reichelt R., Foell D., Gerke V., Manitz M.P., Nacken W., Werner S., Sorg C., and Roth J. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood 104 (2004) 4260-4268
135. Vogl T., Leukert N., Barczyk K., Strupat K., and Roth J. Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations. Biochim. Biophys. Acta 1763 (2006) 1298-1306
136. Wang G., Platt-Higgins A., Carroll J., de Silva Rudland S., Winstanley J., Barraclough R., and Rudland P.S. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res. 66 (2006) 1199-1207
137. Wicki R., Franz C., Scholl F.A., Heizmann C.W., and Schafer B.W. Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell Calcium 22 (1997) 243-254
138. 2+-dependent manner. Protein Sci. 7 (1998) 794-798
139. Wilkinson M.M., Busuttil A., Hayward C., Brock D.J., Dorin J.R., and Van Heyningen V. Expression pattern of two related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues. J. Cell Sci. 91 (1988) 221-230
140. Yao R., Lopez-Beltran A., Maclennan G.T., Montironi R., Eble J.N., and Cheng L. Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res. 27 (2007) 3051-3058
141. Yong H.Y., and Moon A. Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Arch. Pharm. Res. 30 (2007) 75-81
142. Yui S., Yang D., Mikami M., and Yamazaki M. Characterization of cell growth-inhibitory factor in inflammatory peritoneal exudate cells of rats. Microbiol. Immunol. 37 (1993) 961-969
143. Yui S., Mikami M., and Yamazaki M. Induction of apoptotic cell death in mouse lymphoma and human leukemia cell lines by a calcium-binding protein complex, calprotectin, derived from inflammatory peritoneal exudate cells. J. Leukoc. Biol. 58 (1995) 650-658
144. Yui S., Mikami M., Tsurumaki K., and Yamazaki M. Growth-inhibitory and apoptosis-inducing activities of calprotectin derived from inflammatory exudate cells on normal fibroblasts: regulation by metal ions. J. Leukoc. Biol. 61 (1997) 50-57
145. Yui S., Nakatani Y., Hunter M.J., Chazin W.J., and Yamazaki M. Implication of extracellular zinc exclusion by recombinant human calprotectin (MRP8 and MRP14) from target cells in its apoptosis-inducing activity. Mediators Inflamm. 11 (2002) 165-172
146. Yui S., Nakatani Y., and Mikami M. Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol. Pharm. Bull. 26 (2003) 753-760
147. Zali H., Rezaei-Tavirani M., Kariminia A., Yousefi R., and Shokrgozar M.A. Evaluation of growth inhibitory and apoptosis inducing activity of
148. Zhi H., Zhang J., Hu G., Lu J., Wang X., Zhou C., Wu M., and Liu Z. The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma. Int. J. Cancer 106 (2003) 327-333
149. Zimmer D.B., Wright S.P., and Weber D.J. Molecular mechanisms of S100-target protein interactions. Microsc. Res. Tech. 60 (2003) 552-559
150. Zwadlo G., Bruggen J., Gerhards G., Schlegel R., and Sorg C. Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin. Exp. Immunol. 72 (1988) 510-515